Oncology Drugs Market Research Report, Growth & Forecast

The global rare NRG1 fusion market is expected to witness substantial growth, expanding significantly from 2024 and projected to register a strong compound annual growth rate (CAGR) through 2035. This...

The global soft tissue sarcoma market is projected to witness significant growth, expanding from 2024 to 2035 at a notable compound annual growth rate (CAGR). This growth is mainly driven by the incre...

Multiple myeloma is a rare form of blood cancer that originates in plasma cells, a type of white blood cell responsible for producing antibodies (immunoglobulins) that help the body fight infection. I...

Fallopian tube cancer is a rare type of gynaecologic cancer that begins in the fallopian tubes—the thin tubes that connect the ovaries to the uterus. It usually develops from the epithelial cells lini...

Vulvar cancer is a type of cancer that begins as a growth of abnormal cells on the vulva, which is the area of skin surrounding the urethra and vagina, including the clitoris and labia. It often appea...

Neuroblastoma is a rare and aggressive cancer that primarily affects infants and young children, though it can occur in individuals of any age. It arises from immature nerve cells, called neuroblasts,...

Bone metastasis in solid tumors refers to the spread of cancer cells from their primary site (usually in the lungs, breast, prostate, or other solid tumors) to the bones. This is a common complication...

The global tenosynovial giant cell tumors market is experiencing significant growth due to advancements in targeted therapies and increased awareness of the condition. Tenosynovial giant cell tumors a...

Melanoma is a type of skin cancer that originates in the melanocytes, the cells responsible for producing melanin, the pigment that gives skin its color. It is considered one of the most aggressive fo...

The Global Peripheral T-Cell Lymphoma Market focuses on the management and treatment of peripheral T-cell lymphoma, a rare and aggressive type of non-Hodgkin lymphoma that arises from mature T-cells....

The Global Plexiform Neurofibroma Market focuses on the management and treatment of plexiform neurofibromas, complex benign nerve sheath tumors commonly associated with Neurofibromatosis Type 1 (NF1)....

The global metastatic castration-resistant prostate cancer market is evolving rapidly, driven by the growing aging population and high prevalence of prostate cancer worldwide. With limited curative op...

The global large granular lymphocyte leukemia market is witnessing steady growth driven by increasing awareness of chronic lymphoproliferative disorders, improved hematologic diagnostic techniques, an...

Locally advanced pancreatic cancer is an aggressive, unresectable, non-metastatic tumour involving major blood vessels or regional lymph nodes. Therapeutic approaches include combination chemotherapy...

Low grade serous ovarian carcinoma is a rare epithelial ovarian cancer subtype characterised by slow tumour growth, chemoresistance, and frequent recurrence. Current treatments include surgery, hormon...

The global pancreatic neuroendocrine tumors market is witnessing robust growth, driven by increasing incidence rates of pancreatic malignancies, advancements in diagnostic imaging, and expanding thera...

Metastatic breast cancer (mBC) refers to breast cancer that has spread beyond the breast and regional lymph nodes to distant organs, such as bone, liver, lung, or brain. Approximately 70% of breast ca...

Gastroesophageal Adenocarcinoma (GEA) is a type of cancer that develops in the glandular cells of the esophagus or stomach, particularly in the gastroesophageal junction. It occurs when abnormal cells...

The global PD-1 non-small cell lung cancer market is witnessing significant expansion driven by the rising prevalence of lung cancer, increasing adoption of immunotherapies, and continuous innovation...

The global PEComa market is witnessing steady growth driven by the increasing recognition of perivascular epithelioid cell tumors (PEComas) and the adoption of mTOR-targeted therapies such as sirolimu...

The laryngeal cancer market is undergoing notable expansion, driven by a convergence of factors that include advances in treatment methodologies, increasing awareness about early detection, and innova...